Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 13 Feb 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Tofacitinib Citrate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Tofacitinib Citrate API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tofacitinib Citrate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tofacitinib Citrate API that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tofacitinib Citrate API total production and demand, 2018-2029, (Tons)
Global Tofacitinib Citrate API total production value, 2018-2029, (USD Million)
Global Tofacitinib Citrate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Tofacitinib Citrate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Tofacitinib Citrate API domestic production, consumption, key domestic manufacturers and share
Global Tofacitinib Citrate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Tofacitinib Citrate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Tofacitinib Citrate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Tofacitinib Citrate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Huateng Pharma, Beijing Mesochem Technology, CR Double-Crane Pharmaceuticals, Changzhou Pharmaceutical Factory, Chongqing Fuan Pharmaceutical, Sichuan Renan Pharmaceutical, Metrochem API, Dr. Reddy's Laboratories and Kekule Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tofacitinib Citrate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Tofacitinib Citrate API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tofacitinib Citrate API Market, Segmentation by Type
0.98
0.99
Others

Global Tofacitinib Citrate API Market, Segmentation by Application
Tablets
Others

Companies Profiled:
Huateng Pharma
Beijing Mesochem Technology
CR Double-Crane Pharmaceuticals
Changzhou Pharmaceutical Factory
Chongqing Fuan Pharmaceutical
Sichuan Renan Pharmaceutical
Metrochem API
Dr. Reddy's Laboratories
Kekule Pharma
Apotex Pharmachem
Bulat Pharmaceutical
Delmar Chemicals
Glenmark Pharmaceuticals
Kukjeon Pharmaceutical
MSN Laboratories
Mylan Inc
Vitalpharms

Key Questions Answered
1. How big is the global Tofacitinib Citrate API market?
2. What is the demand of the global Tofacitinib Citrate API market?
3. What is the year over year growth of the global Tofacitinib Citrate API market?
4. What is the production and production value of the global Tofacitinib Citrate API market?
5. Who are the key producers in the global Tofacitinib Citrate API market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Tofacitinib Citrate API Introduction
1.2 World Tofacitinib Citrate API Supply & Forecast
1.2.1 World Tofacitinib Citrate API Production Value (2018 & 2022 & 2029)
1.2.2 World Tofacitinib Citrate API Production (2018-2029)
1.2.3 World Tofacitinib Citrate API Pricing Trends (2018-2029)
1.3 World Tofacitinib Citrate API Production by Region (Based on Production Site)
1.3.1 World Tofacitinib Citrate API Production Value by Region (2018-2029)
1.3.2 World Tofacitinib Citrate API Production by Region (2018-2029)
1.3.3 World Tofacitinib Citrate API Average Price by Region (2018-2029)
1.3.4 North America Tofacitinib Citrate API Production (2018-2029)
1.3.5 Europe Tofacitinib Citrate API Production (2018-2029)
1.3.6 China Tofacitinib Citrate API Production (2018-2029)
1.3.7 Japan Tofacitinib Citrate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tofacitinib Citrate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tofacitinib Citrate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Tofacitinib Citrate API Demand (2018-2029)
2.2 World Tofacitinib Citrate API Consumption by Region
2.2.1 World Tofacitinib Citrate API Consumption by Region (2018-2023)
2.2.2 World Tofacitinib Citrate API Consumption Forecast by Region (2024-2029)
2.3 United States Tofacitinib Citrate API Consumption (2018-2029)
2.4 China Tofacitinib Citrate API Consumption (2018-2029)
2.5 Europe Tofacitinib Citrate API Consumption (2018-2029)
2.6 Japan Tofacitinib Citrate API Consumption (2018-2029)
2.7 South Korea Tofacitinib Citrate API Consumption (2018-2029)
2.8 ASEAN Tofacitinib Citrate API Consumption (2018-2029)
2.9 India Tofacitinib Citrate API Consumption (2018-2029)

3 World Tofacitinib Citrate API Manufacturers Competitive Analysis
3.1 World Tofacitinib Citrate API Production Value by Manufacturer (2018-2023)
3.2 World Tofacitinib Citrate API Production by Manufacturer (2018-2023)
3.3 World Tofacitinib Citrate API Average Price by Manufacturer (2018-2023)
3.4 Tofacitinib Citrate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tofacitinib Citrate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tofacitinib Citrate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Tofacitinib Citrate API in 2022
3.6 Tofacitinib Citrate API Market: Overall Company Footprint Analysis
3.6.1 Tofacitinib Citrate API Market: Region Footprint
3.6.2 Tofacitinib Citrate API Market: Company Product Type Footprint
3.6.3 Tofacitinib Citrate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Tofacitinib Citrate API Production Value Comparison
4.1.1 United States VS China: Tofacitinib Citrate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tofacitinib Citrate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tofacitinib Citrate API Production Comparison
4.2.1 United States VS China: Tofacitinib Citrate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tofacitinib Citrate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tofacitinib Citrate API Consumption Comparison
4.3.1 United States VS China: Tofacitinib Citrate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tofacitinib Citrate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tofacitinib Citrate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tofacitinib Citrate API Production (2018-2023)
4.5 China Based Tofacitinib Citrate API Manufacturers and Market Share
4.5.1 China Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Tofacitinib Citrate API Production (2018-2023)
4.6 Rest of World Based Tofacitinib Citrate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tofacitinib Citrate API Production (2018-2023)

5 Market Analysis by Type
5.1 World Tofacitinib Citrate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.98
5.2.2 0.99
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Tofacitinib Citrate API Production by Type (2018-2029)
5.3.2 World Tofacitinib Citrate API Production Value by Type (2018-2029)
5.3.3 World Tofacitinib Citrate API Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Tofacitinib Citrate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tablets
6.2.2 Others
6.3 Market Segment by Application
6.3.1 World Tofacitinib Citrate API Production by Application (2018-2029)
6.3.2 World Tofacitinib Citrate API Production Value by Application (2018-2029)
6.3.3 World Tofacitinib Citrate API Average Price by Application (2018-2029)

7 Company Profiles
7.1 Huateng Pharma
7.1.1 Huateng Pharma Details
7.1.2 Huateng Pharma Major Business
7.1.3 Huateng Pharma Tofacitinib Citrate API Product and Services
7.1.4 Huateng Pharma Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Huateng Pharma Recent Developments/Updates
7.1.6 Huateng Pharma Competitive Strengths & Weaknesses
7.2 Beijing Mesochem Technology
7.2.1 Beijing Mesochem Technology Details
7.2.2 Beijing Mesochem Technology Major Business
7.2.3 Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
7.2.4 Beijing Mesochem Technology Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Beijing Mesochem Technology Recent Developments/Updates
7.2.6 Beijing Mesochem Technology Competitive Strengths & Weaknesses
7.3 CR Double-Crane Pharmaceuticals
7.3.1 CR Double-Crane Pharmaceuticals Details
7.3.2 CR Double-Crane Pharmaceuticals Major Business
7.3.3 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
7.3.4 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CR Double-Crane Pharmaceuticals Recent Developments/Updates
7.3.6 CR Double-Crane Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Changzhou Pharmaceutical Factory
7.4.1 Changzhou Pharmaceutical Factory Details
7.4.2 Changzhou Pharmaceutical Factory Major Business
7.4.3 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
7.4.4 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.4.6 Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
7.5 Chongqing Fuan Pharmaceutical
7.5.1 Chongqing Fuan Pharmaceutical Details
7.5.2 Chongqing Fuan Pharmaceutical Major Business
7.5.3 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
7.5.4 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Chongqing Fuan Pharmaceutical Recent Developments/Updates
7.5.6 Chongqing Fuan Pharmaceutical Competitive Strengths & Weaknesses
7.6 Sichuan Renan Pharmaceutical
7.6.1 Sichuan Renan Pharmaceutical Details
7.6.2 Sichuan Renan Pharmaceutical Major Business
7.6.3 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
7.6.4 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sichuan Renan Pharmaceutical Recent Developments/Updates
7.6.6 Sichuan Renan Pharmaceutical Competitive Strengths & Weaknesses
7.7 Metrochem API
7.7.1 Metrochem API Details
7.7.2 Metrochem API Major Business
7.7.3 Metrochem API Tofacitinib Citrate API Product and Services
7.7.4 Metrochem API Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Metrochem API Recent Developments/Updates
7.7.6 Metrochem API Competitive Strengths & Weaknesses
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Details
7.8.2 Dr. Reddy's Laboratories Major Business
7.8.3 Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
7.8.4 Dr. Reddy's Laboratories Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.8.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
7.9 Kekule Pharma
7.9.1 Kekule Pharma Details
7.9.2 Kekule Pharma Major Business
7.9.3 Kekule Pharma Tofacitinib Citrate API Product and Services
7.9.4 Kekule Pharma Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kekule Pharma Recent Developments/Updates
7.9.6 Kekule Pharma Competitive Strengths & Weaknesses
7.10 Apotex Pharmachem
7.10.1 Apotex Pharmachem Details
7.10.2 Apotex Pharmachem Major Business
7.10.3 Apotex Pharmachem Tofacitinib Citrate API Product and Services
7.10.4 Apotex Pharmachem Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Apotex Pharmachem Recent Developments/Updates
7.10.6 Apotex Pharmachem Competitive Strengths & Weaknesses
7.11 Bulat Pharmaceutical
7.11.1 Bulat Pharmaceutical Details
7.11.2 Bulat Pharmaceutical Major Business
7.11.3 Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
7.11.4 Bulat Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Bulat Pharmaceutical Recent Developments/Updates
7.11.6 Bulat Pharmaceutical Competitive Strengths & Weaknesses
7.12 Delmar Chemicals
7.12.1 Delmar Chemicals Details
7.12.2 Delmar Chemicals Major Business
7.12.3 Delmar Chemicals Tofacitinib Citrate API Product and Services
7.12.4 Delmar Chemicals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Delmar Chemicals Recent Developments/Updates
7.12.6 Delmar Chemicals Competitive Strengths & Weaknesses
7.13 Glenmark Pharmaceuticals
7.13.1 Glenmark Pharmaceuticals Details
7.13.2 Glenmark Pharmaceuticals Major Business
7.13.3 Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
7.13.4 Glenmark Pharmaceuticals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.13.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Kukjeon Pharmaceutical
7.14.1 Kukjeon Pharmaceutical Details
7.14.2 Kukjeon Pharmaceutical Major Business
7.14.3 Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
7.14.4 Kukjeon Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Kukjeon Pharmaceutical Recent Developments/Updates
7.14.6 Kukjeon Pharmaceutical Competitive Strengths & Weaknesses
7.15 MSN Laboratories
7.15.1 MSN Laboratories Details
7.15.2 MSN Laboratories Major Business
7.15.3 MSN Laboratories Tofacitinib Citrate API Product and Services
7.15.4 MSN Laboratories Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 MSN Laboratories Recent Developments/Updates
7.15.6 MSN Laboratories Competitive Strengths & Weaknesses
7.16 Mylan Inc
7.16.1 Mylan Inc Details
7.16.2 Mylan Inc Major Business
7.16.3 Mylan Inc Tofacitinib Citrate API Product and Services
7.16.4 Mylan Inc Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Mylan Inc Recent Developments/Updates
7.16.6 Mylan Inc Competitive Strengths & Weaknesses
7.17 Vitalpharms
7.17.1 Vitalpharms Details
7.17.2 Vitalpharms Major Business
7.17.3 Vitalpharms Tofacitinib Citrate API Product and Services
7.17.4 Vitalpharms Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Vitalpharms Recent Developments/Updates
7.17.6 Vitalpharms Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Tofacitinib Citrate API Industry Chain
8.2 Tofacitinib Citrate API Upstream Analysis
8.2.1 Tofacitinib Citrate API Core Raw Materials
8.2.2 Main Manufacturers of Tofacitinib Citrate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tofacitinib Citrate API Production Mode
8.6 Tofacitinib Citrate API Procurement Model
8.7 Tofacitinib Citrate API Industry Sales Model and Sales Channels
8.7.1 Tofacitinib Citrate API Sales Model
8.7.2 Tofacitinib Citrate API Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Tofacitinib Citrate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tofacitinib Citrate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tofacitinib Citrate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tofacitinib Citrate API Production Value Market Share by Region (2018-2023)
Table 5. World Tofacitinib Citrate API Production Value Market Share by Region (2024-2029)
Table 6. World Tofacitinib Citrate API Production by Region (2018-2023) & (Tons)
Table 7. World Tofacitinib Citrate API Production by Region (2024-2029) & (Tons)
Table 8. World Tofacitinib Citrate API Production Market Share by Region (2018-2023)
Table 9. World Tofacitinib Citrate API Production Market Share by Region (2024-2029)
Table 10. World Tofacitinib Citrate API Average Price by Region (2018-2023) & (US$/Kg)
Table 11. World Tofacitinib Citrate API Average Price by Region (2024-2029) & (US$/Kg)
Table 12. Tofacitinib Citrate API Major Market Trends
Table 13. World Tofacitinib Citrate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Tofacitinib Citrate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Tofacitinib Citrate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Tofacitinib Citrate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tofacitinib Citrate API Producers in 2022
Table 18. World Tofacitinib Citrate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Tofacitinib Citrate API Producers in 2022
Table 20. World Tofacitinib Citrate API Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 21. Global Tofacitinib Citrate API Company Evaluation Quadrant
Table 22. World Tofacitinib Citrate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tofacitinib Citrate API Production Site of Key Manufacturer
Table 24. Tofacitinib Citrate API Market: Company Product Type Footprint
Table 25. Tofacitinib Citrate API Market: Company Product Application Footprint
Table 26. Tofacitinib Citrate API Competitive Factors
Table 27. Tofacitinib Citrate API New Entrant and Capacity Expansion Plans
Table 28. Tofacitinib Citrate API Mergers & Acquisitions Activity
Table 29. United States VS China Tofacitinib Citrate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tofacitinib Citrate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Tofacitinib Citrate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 37. China Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 42. Rest of World Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 47. World Tofacitinib Citrate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tofacitinib Citrate API Production by Type (2018-2023) & (Tons)
Table 49. World Tofacitinib Citrate API Production by Type (2024-2029) & (Tons)
Table 50. World Tofacitinib Citrate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tofacitinib Citrate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tofacitinib Citrate API Average Price by Type (2018-2023) & (US$/Kg)
Table 53. World Tofacitinib Citrate API Average Price by Type (2024-2029) & (US$/Kg)
Table 54. World Tofacitinib Citrate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tofacitinib Citrate API Production by Application (2018-2023) & (Tons)
Table 56. World Tofacitinib Citrate API Production by Application (2024-2029) & (Tons)
Table 57. World Tofacitinib Citrate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tofacitinib Citrate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tofacitinib Citrate API Average Price by Application (2018-2023) & (US$/Kg)
Table 60. World Tofacitinib Citrate API Average Price by Application (2024-2029) & (US$/Kg)
Table 61. Huateng Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Huateng Pharma Major Business
Table 63. Huateng Pharma Tofacitinib Citrate API Product and Services
Table 64. Huateng Pharma Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Huateng Pharma Recent Developments/Updates
Table 66. Huateng Pharma Competitive Strengths & Weaknesses
Table 67. Beijing Mesochem Technology Basic Information, Manufacturing Base and Competitors
Table 68. Beijing Mesochem Technology Major Business
Table 69. Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
Table 70. Beijing Mesochem Technology Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Beijing Mesochem Technology Recent Developments/Updates
Table 72. Beijing Mesochem Technology Competitive Strengths & Weaknesses
Table 73. CR Double-Crane Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. CR Double-Crane Pharmaceuticals Major Business
Table 75. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
Table 76. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CR Double-Crane Pharmaceuticals Recent Developments/Updates
Table 78. CR Double-Crane Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 80. Changzhou Pharmaceutical Factory Major Business
Table 81. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
Table 82. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 84. Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
Table 85. Chongqing Fuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Chongqing Fuan Pharmaceutical Major Business
Table 87. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
Table 88. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Chongqing Fuan Pharmaceutical Recent Developments/Updates
Table 90. Chongqing Fuan Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Sichuan Renan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Sichuan Renan Pharmaceutical Major Business
Table 93. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
Table 94. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sichuan Renan Pharmaceutical Recent Developments/Updates
Table 96. Sichuan Renan Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Metrochem API Basic Information, Manufacturing Base and Competitors
Table 98. Metrochem API Major Business
Table 99. Metrochem API Tofacitinib Citrate API Product and Services
Table 100. Metrochem API Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Metrochem API Recent Developments/Updates
Table 102. Metrochem API Competitive Strengths & Weaknesses
Table 103. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 104. Dr. Reddy's Laboratories Major Business
Table 105. Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
Table 106. Dr. Reddy's Laboratories Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Dr. Reddy's Laboratories Recent Developments/Updates
Table 108. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 109. Kekule Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Kekule Pharma Major Business
Table 111. Kekule Pharma Tofacitinib Citrate API Product and Services
Table 112. Kekule Pharma Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Kekule Pharma Recent Developments/Updates
Table 114. Kekule Pharma Competitive Strengths & Weaknesses
Table 115. Apotex Pharmachem Basic Information, Manufacturing Base and Competitors
Table 116. Apotex Pharmachem Major Business
Table 117. Apotex Pharmachem Tofacitinib Citrate API Product and Services
Table 118. Apotex Pharmachem Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Apotex Pharmachem Recent Developments/Updates
Table 120. Apotex Pharmachem Competitive Strengths & Weaknesses
Table 121. Bulat Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Bulat Pharmaceutical Major Business
Table 123. Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
Table 124. Bulat Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Bulat Pharmaceutical Recent Developments/Updates
Table 126. Bulat Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Delmar Chemicals Basic Information, Manufacturing Base and Competitors
Table 128. Delmar Chemicals Major Business
Table 129. Delmar Chemicals Tofacitinib Citrate API Product and Services
Table 130. Delmar Chemicals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Delmar Chemicals Recent Developments/Updates
Table 132. Delmar Chemicals Competitive Strengths & Weaknesses
Table 133. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Glenmark Pharmaceuticals Major Business
Table 135. Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
Table 136. Glenmark Pharmaceuticals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Glenmark Pharmaceuticals Recent Developments/Updates
Table 138. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Kukjeon Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Kukjeon Pharmaceutical Major Business
Table 141. Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
Table 142. Kukjeon Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Kukjeon Pharmaceutical Recent Developments/Updates
Table 144. Kukjeon Pharmaceutical Competitive Strengths & Weaknesses
Table 145. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 146. MSN Laboratories Major Business
Table 147. MSN Laboratories Tofacitinib Citrate API Product and Services
Table 148. MSN Laboratories Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. MSN Laboratories Recent Developments/Updates
Table 150. MSN Laboratories Competitive Strengths & Weaknesses
Table 151. Mylan Inc Basic Information, Manufacturing Base and Competitors
Table 152. Mylan Inc Major Business
Table 153. Mylan Inc Tofacitinib Citrate API Product and Services
Table 154. Mylan Inc Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Mylan Inc Recent Developments/Updates
Table 156. Vitalpharms Basic Information, Manufacturing Base and Competitors
Table 157. Vitalpharms Major Business
Table 158. Vitalpharms Tofacitinib Citrate API Product and Services
Table 159. Vitalpharms Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Tofacitinib Citrate API Upstream (Raw Materials)
Table 161. Tofacitinib Citrate API Typical Customers
Table 162. Tofacitinib Citrate API Typical Distributors
List of Figure
Figure 1. Tofacitinib Citrate API Picture
Figure 2. World Tofacitinib Citrate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tofacitinib Citrate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 5. World Tofacitinib Citrate API Average Price (2018-2029) & (US$/Kg)
Figure 6. World Tofacitinib Citrate API Production Value Market Share by Region (2018-2029)
Figure 7. World Tofacitinib Citrate API Production Market Share by Region (2018-2029)
Figure 8. North America Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 9. Europe Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 10. China Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 11. Japan Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 12. Tofacitinib Citrate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 15. World Tofacitinib Citrate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 17. China Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 22. India Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Tofacitinib Citrate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tofacitinib Citrate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tofacitinib Citrate API Markets in 2022
Figure 26. United States VS China: Tofacitinib Citrate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tofacitinib Citrate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tofacitinib Citrate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 30. China Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 32. World Tofacitinib Citrate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tofacitinib Citrate API Production Value Market Share by Type in 2022
Figure 34. 0.98
Figure 35. 0.99
Figure 36. Others
Figure 37. World Tofacitinib Citrate API Production Market Share by Type (2018-2029)
Figure 38. World Tofacitinib Citrate API Production Value Market Share by Type (2018-2029)
Figure 39. World Tofacitinib Citrate API Average Price by Type (2018-2029) & (US$/Kg)
Figure 40. World Tofacitinib Citrate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Tofacitinib Citrate API Production Value Market Share by Application in 2022
Figure 42. Tablets
Figure 43. Others
Figure 44. World Tofacitinib Citrate API Production Market Share by Application (2018-2029)
Figure 45. World Tofacitinib Citrate API Production Value Market Share by Application (2018-2029)
Figure 46. World Tofacitinib Citrate API Average Price by Application (2018-2029) & (US$/Kg)
Figure 47. Tofacitinib Citrate API Industry Chain
Figure 48. Tofacitinib Citrate API Procurement Model
Figure 49. Tofacitinib Citrate API Sales Model
Figure 50. Tofacitinib Citrate API Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

Global Tofacitinib Citrate API Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 13 Feb 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Tofacitinib Citrate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Tofacitinib Citrate API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tofacitinib Citrate API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tofacitinib Citrate API that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tofacitinib Citrate API total production and demand, 2018-2029, (Tons)
Global Tofacitinib Citrate API total production value, 2018-2029, (USD Million)
Global Tofacitinib Citrate API production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Tofacitinib Citrate API consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Tofacitinib Citrate API domestic production, consumption, key domestic manufacturers and share
Global Tofacitinib Citrate API production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Tofacitinib Citrate API production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Tofacitinib Citrate API production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons)
This reports profiles key players in the global Tofacitinib Citrate API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Huateng Pharma, Beijing Mesochem Technology, CR Double-Crane Pharmaceuticals, Changzhou Pharmaceutical Factory, Chongqing Fuan Pharmaceutical, Sichuan Renan Pharmaceutical, Metrochem API, Dr. Reddy's Laboratories and Kekule Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tofacitinib Citrate API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Tofacitinib Citrate API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tofacitinib Citrate API Market, Segmentation by Type
0.98
0.99
Others

Global Tofacitinib Citrate API Market, Segmentation by Application
Tablets
Others

Companies Profiled:
Huateng Pharma
Beijing Mesochem Technology
CR Double-Crane Pharmaceuticals
Changzhou Pharmaceutical Factory
Chongqing Fuan Pharmaceutical
Sichuan Renan Pharmaceutical
Metrochem API
Dr. Reddy's Laboratories
Kekule Pharma
Apotex Pharmachem
Bulat Pharmaceutical
Delmar Chemicals
Glenmark Pharmaceuticals
Kukjeon Pharmaceutical
MSN Laboratories
Mylan Inc
Vitalpharms

Key Questions Answered
1. How big is the global Tofacitinib Citrate API market?
2. What is the demand of the global Tofacitinib Citrate API market?
3. What is the year over year growth of the global Tofacitinib Citrate API market?
4. What is the production and production value of the global Tofacitinib Citrate API market?
5. Who are the key producers in the global Tofacitinib Citrate API market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Tofacitinib Citrate API Introduction
1.2 World Tofacitinib Citrate API Supply & Forecast
1.2.1 World Tofacitinib Citrate API Production Value (2018 & 2022 & 2029)
1.2.2 World Tofacitinib Citrate API Production (2018-2029)
1.2.3 World Tofacitinib Citrate API Pricing Trends (2018-2029)
1.3 World Tofacitinib Citrate API Production by Region (Based on Production Site)
1.3.1 World Tofacitinib Citrate API Production Value by Region (2018-2029)
1.3.2 World Tofacitinib Citrate API Production by Region (2018-2029)
1.3.3 World Tofacitinib Citrate API Average Price by Region (2018-2029)
1.3.4 North America Tofacitinib Citrate API Production (2018-2029)
1.3.5 Europe Tofacitinib Citrate API Production (2018-2029)
1.3.6 China Tofacitinib Citrate API Production (2018-2029)
1.3.7 Japan Tofacitinib Citrate API Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tofacitinib Citrate API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tofacitinib Citrate API Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Tofacitinib Citrate API Demand (2018-2029)
2.2 World Tofacitinib Citrate API Consumption by Region
2.2.1 World Tofacitinib Citrate API Consumption by Region (2018-2023)
2.2.2 World Tofacitinib Citrate API Consumption Forecast by Region (2024-2029)
2.3 United States Tofacitinib Citrate API Consumption (2018-2029)
2.4 China Tofacitinib Citrate API Consumption (2018-2029)
2.5 Europe Tofacitinib Citrate API Consumption (2018-2029)
2.6 Japan Tofacitinib Citrate API Consumption (2018-2029)
2.7 South Korea Tofacitinib Citrate API Consumption (2018-2029)
2.8 ASEAN Tofacitinib Citrate API Consumption (2018-2029)
2.9 India Tofacitinib Citrate API Consumption (2018-2029)

3 World Tofacitinib Citrate API Manufacturers Competitive Analysis
3.1 World Tofacitinib Citrate API Production Value by Manufacturer (2018-2023)
3.2 World Tofacitinib Citrate API Production by Manufacturer (2018-2023)
3.3 World Tofacitinib Citrate API Average Price by Manufacturer (2018-2023)
3.4 Tofacitinib Citrate API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Tofacitinib Citrate API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Tofacitinib Citrate API in 2022
3.5.3 Global Concentration Ratios (CR8) for Tofacitinib Citrate API in 2022
3.6 Tofacitinib Citrate API Market: Overall Company Footprint Analysis
3.6.1 Tofacitinib Citrate API Market: Region Footprint
3.6.2 Tofacitinib Citrate API Market: Company Product Type Footprint
3.6.3 Tofacitinib Citrate API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Tofacitinib Citrate API Production Value Comparison
4.1.1 United States VS China: Tofacitinib Citrate API Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Tofacitinib Citrate API Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Tofacitinib Citrate API Production Comparison
4.2.1 United States VS China: Tofacitinib Citrate API Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tofacitinib Citrate API Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Tofacitinib Citrate API Consumption Comparison
4.3.1 United States VS China: Tofacitinib Citrate API Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Tofacitinib Citrate API Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Tofacitinib Citrate API Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.4.3 United States Based Manufacturers Tofacitinib Citrate API Production (2018-2023)
4.5 China Based Tofacitinib Citrate API Manufacturers and Market Share
4.5.1 China Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.5.3 China Based Manufacturers Tofacitinib Citrate API Production (2018-2023)
4.6 Rest of World Based Tofacitinib Citrate API Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Tofacitinib Citrate API Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Tofacitinib Citrate API Production (2018-2023)

5 Market Analysis by Type
5.1 World Tofacitinib Citrate API Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.98
5.2.2 0.99
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Tofacitinib Citrate API Production by Type (2018-2029)
5.3.2 World Tofacitinib Citrate API Production Value by Type (2018-2029)
5.3.3 World Tofacitinib Citrate API Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Tofacitinib Citrate API Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Tablets
6.2.2 Others
6.3 Market Segment by Application
6.3.1 World Tofacitinib Citrate API Production by Application (2018-2029)
6.3.2 World Tofacitinib Citrate API Production Value by Application (2018-2029)
6.3.3 World Tofacitinib Citrate API Average Price by Application (2018-2029)

7 Company Profiles
7.1 Huateng Pharma
7.1.1 Huateng Pharma Details
7.1.2 Huateng Pharma Major Business
7.1.3 Huateng Pharma Tofacitinib Citrate API Product and Services
7.1.4 Huateng Pharma Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Huateng Pharma Recent Developments/Updates
7.1.6 Huateng Pharma Competitive Strengths & Weaknesses
7.2 Beijing Mesochem Technology
7.2.1 Beijing Mesochem Technology Details
7.2.2 Beijing Mesochem Technology Major Business
7.2.3 Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
7.2.4 Beijing Mesochem Technology Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Beijing Mesochem Technology Recent Developments/Updates
7.2.6 Beijing Mesochem Technology Competitive Strengths & Weaknesses
7.3 CR Double-Crane Pharmaceuticals
7.3.1 CR Double-Crane Pharmaceuticals Details
7.3.2 CR Double-Crane Pharmaceuticals Major Business
7.3.3 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
7.3.4 CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CR Double-Crane Pharmaceuticals Recent Developments/Updates
7.3.6 CR Double-Crane Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Changzhou Pharmaceutical Factory
7.4.1 Changzhou Pharmaceutical Factory Details
7.4.2 Changzhou Pharmaceutical Factory Major Business
7.4.3 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
7.4.4 Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7.4.6 Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
7.5 Chongqing Fuan Pharmaceutical
7.5.1 Chongqing Fuan Pharmaceutical Details
7.5.2 Chongqing Fuan Pharmaceutical Major Business
7.5.3 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
7.5.4 Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Chongqing Fuan Pharmaceutical Recent Developments/Updates
7.5.6 Chongqing Fuan Pharmaceutical Competitive Strengths & Weaknesses
7.6 Sichuan Renan Pharmaceutical
7.6.1 Sichuan Renan Pharmaceutical Details
7.6.2 Sichuan Renan Pharmaceutical Major Business
7.6.3 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
7.6.4 Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sichuan Renan Pharmaceutical Recent Developments/Updates
7.6.6 Sichuan Renan Pharmaceutical Competitive Strengths & Weaknesses
7.7 Metrochem API
7.7.1 Metrochem API Details
7.7.2 Metrochem API Major Business
7.7.3 Metrochem API Tofacitinib Citrate API Product and Services
7.7.4 Metrochem API Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Metrochem API Recent Developments/Updates
7.7.6 Metrochem API Competitive Strengths & Weaknesses
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Details
7.8.2 Dr. Reddy's Laboratories Major Business
7.8.3 Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
7.8.4 Dr. Reddy's Laboratories Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.8.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
7.9 Kekule Pharma
7.9.1 Kekule Pharma Details
7.9.2 Kekule Pharma Major Business
7.9.3 Kekule Pharma Tofacitinib Citrate API Product and Services
7.9.4 Kekule Pharma Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kekule Pharma Recent Developments/Updates
7.9.6 Kekule Pharma Competitive Strengths & Weaknesses
7.10 Apotex Pharmachem
7.10.1 Apotex Pharmachem Details
7.10.2 Apotex Pharmachem Major Business
7.10.3 Apotex Pharmachem Tofacitinib Citrate API Product and Services
7.10.4 Apotex Pharmachem Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Apotex Pharmachem Recent Developments/Updates
7.10.6 Apotex Pharmachem Competitive Strengths & Weaknesses
7.11 Bulat Pharmaceutical
7.11.1 Bulat Pharmaceutical Details
7.11.2 Bulat Pharmaceutical Major Business
7.11.3 Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
7.11.4 Bulat Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Bulat Pharmaceutical Recent Developments/Updates
7.11.6 Bulat Pharmaceutical Competitive Strengths & Weaknesses
7.12 Delmar Chemicals
7.12.1 Delmar Chemicals Details
7.12.2 Delmar Chemicals Major Business
7.12.3 Delmar Chemicals Tofacitinib Citrate API Product and Services
7.12.4 Delmar Chemicals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Delmar Chemicals Recent Developments/Updates
7.12.6 Delmar Chemicals Competitive Strengths & Weaknesses
7.13 Glenmark Pharmaceuticals
7.13.1 Glenmark Pharmaceuticals Details
7.13.2 Glenmark Pharmaceuticals Major Business
7.13.3 Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
7.13.4 Glenmark Pharmaceuticals Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.13.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Kukjeon Pharmaceutical
7.14.1 Kukjeon Pharmaceutical Details
7.14.2 Kukjeon Pharmaceutical Major Business
7.14.3 Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
7.14.4 Kukjeon Pharmaceutical Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Kukjeon Pharmaceutical Recent Developments/Updates
7.14.6 Kukjeon Pharmaceutical Competitive Strengths & Weaknesses
7.15 MSN Laboratories
7.15.1 MSN Laboratories Details
7.15.2 MSN Laboratories Major Business
7.15.3 MSN Laboratories Tofacitinib Citrate API Product and Services
7.15.4 MSN Laboratories Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 MSN Laboratories Recent Developments/Updates
7.15.6 MSN Laboratories Competitive Strengths & Weaknesses
7.16 Mylan Inc
7.16.1 Mylan Inc Details
7.16.2 Mylan Inc Major Business
7.16.3 Mylan Inc Tofacitinib Citrate API Product and Services
7.16.4 Mylan Inc Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Mylan Inc Recent Developments/Updates
7.16.6 Mylan Inc Competitive Strengths & Weaknesses
7.17 Vitalpharms
7.17.1 Vitalpharms Details
7.17.2 Vitalpharms Major Business
7.17.3 Vitalpharms Tofacitinib Citrate API Product and Services
7.17.4 Vitalpharms Tofacitinib Citrate API Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Vitalpharms Recent Developments/Updates
7.17.6 Vitalpharms Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Tofacitinib Citrate API Industry Chain
8.2 Tofacitinib Citrate API Upstream Analysis
8.2.1 Tofacitinib Citrate API Core Raw Materials
8.2.2 Main Manufacturers of Tofacitinib Citrate API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Tofacitinib Citrate API Production Mode
8.6 Tofacitinib Citrate API Procurement Model
8.7 Tofacitinib Citrate API Industry Sales Model and Sales Channels
8.7.1 Tofacitinib Citrate API Sales Model
8.7.2 Tofacitinib Citrate API Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Tofacitinib Citrate API Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Tofacitinib Citrate API Production Value by Region (2018-2023) & (USD Million)
Table 3. World Tofacitinib Citrate API Production Value by Region (2024-2029) & (USD Million)
Table 4. World Tofacitinib Citrate API Production Value Market Share by Region (2018-2023)
Table 5. World Tofacitinib Citrate API Production Value Market Share by Region (2024-2029)
Table 6. World Tofacitinib Citrate API Production by Region (2018-2023) & (Tons)
Table 7. World Tofacitinib Citrate API Production by Region (2024-2029) & (Tons)
Table 8. World Tofacitinib Citrate API Production Market Share by Region (2018-2023)
Table 9. World Tofacitinib Citrate API Production Market Share by Region (2024-2029)
Table 10. World Tofacitinib Citrate API Average Price by Region (2018-2023) & (US$/Kg)
Table 11. World Tofacitinib Citrate API Average Price by Region (2024-2029) & (US$/Kg)
Table 12. Tofacitinib Citrate API Major Market Trends
Table 13. World Tofacitinib Citrate API Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Tofacitinib Citrate API Consumption by Region (2018-2023) & (Tons)
Table 15. World Tofacitinib Citrate API Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Tofacitinib Citrate API Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Tofacitinib Citrate API Producers in 2022
Table 18. World Tofacitinib Citrate API Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Tofacitinib Citrate API Producers in 2022
Table 20. World Tofacitinib Citrate API Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 21. Global Tofacitinib Citrate API Company Evaluation Quadrant
Table 22. World Tofacitinib Citrate API Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Tofacitinib Citrate API Production Site of Key Manufacturer
Table 24. Tofacitinib Citrate API Market: Company Product Type Footprint
Table 25. Tofacitinib Citrate API Market: Company Product Application Footprint
Table 26. Tofacitinib Citrate API Competitive Factors
Table 27. Tofacitinib Citrate API New Entrant and Capacity Expansion Plans
Table 28. Tofacitinib Citrate API Mergers & Acquisitions Activity
Table 29. United States VS China Tofacitinib Citrate API Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Tofacitinib Citrate API Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Tofacitinib Citrate API Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 37. China Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 42. Rest of World Based Tofacitinib Citrate API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Tofacitinib Citrate API Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Tofacitinib Citrate API Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Tofacitinib Citrate API Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Tofacitinib Citrate API Production Market Share (2018-2023)
Table 47. World Tofacitinib Citrate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Tofacitinib Citrate API Production by Type (2018-2023) & (Tons)
Table 49. World Tofacitinib Citrate API Production by Type (2024-2029) & (Tons)
Table 50. World Tofacitinib Citrate API Production Value by Type (2018-2023) & (USD Million)
Table 51. World Tofacitinib Citrate API Production Value by Type (2024-2029) & (USD Million)
Table 52. World Tofacitinib Citrate API Average Price by Type (2018-2023) & (US$/Kg)
Table 53. World Tofacitinib Citrate API Average Price by Type (2024-2029) & (US$/Kg)
Table 54. World Tofacitinib Citrate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Tofacitinib Citrate API Production by Application (2018-2023) & (Tons)
Table 56. World Tofacitinib Citrate API Production by Application (2024-2029) & (Tons)
Table 57. World Tofacitinib Citrate API Production Value by Application (2018-2023) & (USD Million)
Table 58. World Tofacitinib Citrate API Production Value by Application (2024-2029) & (USD Million)
Table 59. World Tofacitinib Citrate API Average Price by Application (2018-2023) & (US$/Kg)
Table 60. World Tofacitinib Citrate API Average Price by Application (2024-2029) & (US$/Kg)
Table 61. Huateng Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Huateng Pharma Major Business
Table 63. Huateng Pharma Tofacitinib Citrate API Product and Services
Table 64. Huateng Pharma Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Huateng Pharma Recent Developments/Updates
Table 66. Huateng Pharma Competitive Strengths & Weaknesses
Table 67. Beijing Mesochem Technology Basic Information, Manufacturing Base and Competitors
Table 68. Beijing Mesochem Technology Major Business
Table 69. Beijing Mesochem Technology Tofacitinib Citrate API Product and Services
Table 70. Beijing Mesochem Technology Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Beijing Mesochem Technology Recent Developments/Updates
Table 72. Beijing Mesochem Technology Competitive Strengths & Weaknesses
Table 73. CR Double-Crane Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. CR Double-Crane Pharmaceuticals Major Business
Table 75. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Product and Services
Table 76. CR Double-Crane Pharmaceuticals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CR Double-Crane Pharmaceuticals Recent Developments/Updates
Table 78. CR Double-Crane Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Changzhou Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 80. Changzhou Pharmaceutical Factory Major Business
Table 81. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Product and Services
Table 82. Changzhou Pharmaceutical Factory Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 84. Changzhou Pharmaceutical Factory Competitive Strengths & Weaknesses
Table 85. Chongqing Fuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Chongqing Fuan Pharmaceutical Major Business
Table 87. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Product and Services
Table 88. Chongqing Fuan Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Chongqing Fuan Pharmaceutical Recent Developments/Updates
Table 90. Chongqing Fuan Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Sichuan Renan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Sichuan Renan Pharmaceutical Major Business
Table 93. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Product and Services
Table 94. Sichuan Renan Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sichuan Renan Pharmaceutical Recent Developments/Updates
Table 96. Sichuan Renan Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Metrochem API Basic Information, Manufacturing Base and Competitors
Table 98. Metrochem API Major Business
Table 99. Metrochem API Tofacitinib Citrate API Product and Services
Table 100. Metrochem API Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Metrochem API Recent Developments/Updates
Table 102. Metrochem API Competitive Strengths & Weaknesses
Table 103. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 104. Dr. Reddy's Laboratories Major Business
Table 105. Dr. Reddy's Laboratories Tofacitinib Citrate API Product and Services
Table 106. Dr. Reddy's Laboratories Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Dr. Reddy's Laboratories Recent Developments/Updates
Table 108. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 109. Kekule Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Kekule Pharma Major Business
Table 111. Kekule Pharma Tofacitinib Citrate API Product and Services
Table 112. Kekule Pharma Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Kekule Pharma Recent Developments/Updates
Table 114. Kekule Pharma Competitive Strengths & Weaknesses
Table 115. Apotex Pharmachem Basic Information, Manufacturing Base and Competitors
Table 116. Apotex Pharmachem Major Business
Table 117. Apotex Pharmachem Tofacitinib Citrate API Product and Services
Table 118. Apotex Pharmachem Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Apotex Pharmachem Recent Developments/Updates
Table 120. Apotex Pharmachem Competitive Strengths & Weaknesses
Table 121. Bulat Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Bulat Pharmaceutical Major Business
Table 123. Bulat Pharmaceutical Tofacitinib Citrate API Product and Services
Table 124. Bulat Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Bulat Pharmaceutical Recent Developments/Updates
Table 126. Bulat Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Delmar Chemicals Basic Information, Manufacturing Base and Competitors
Table 128. Delmar Chemicals Major Business
Table 129. Delmar Chemicals Tofacitinib Citrate API Product and Services
Table 130. Delmar Chemicals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Delmar Chemicals Recent Developments/Updates
Table 132. Delmar Chemicals Competitive Strengths & Weaknesses
Table 133. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Glenmark Pharmaceuticals Major Business
Table 135. Glenmark Pharmaceuticals Tofacitinib Citrate API Product and Services
Table 136. Glenmark Pharmaceuticals Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Glenmark Pharmaceuticals Recent Developments/Updates
Table 138. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Kukjeon Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Kukjeon Pharmaceutical Major Business
Table 141. Kukjeon Pharmaceutical Tofacitinib Citrate API Product and Services
Table 142. Kukjeon Pharmaceutical Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Kukjeon Pharmaceutical Recent Developments/Updates
Table 144. Kukjeon Pharmaceutical Competitive Strengths & Weaknesses
Table 145. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 146. MSN Laboratories Major Business
Table 147. MSN Laboratories Tofacitinib Citrate API Product and Services
Table 148. MSN Laboratories Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. MSN Laboratories Recent Developments/Updates
Table 150. MSN Laboratories Competitive Strengths & Weaknesses
Table 151. Mylan Inc Basic Information, Manufacturing Base and Competitors
Table 152. Mylan Inc Major Business
Table 153. Mylan Inc Tofacitinib Citrate API Product and Services
Table 154. Mylan Inc Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Mylan Inc Recent Developments/Updates
Table 156. Vitalpharms Basic Information, Manufacturing Base and Competitors
Table 157. Vitalpharms Major Business
Table 158. Vitalpharms Tofacitinib Citrate API Product and Services
Table 159. Vitalpharms Tofacitinib Citrate API Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Tofacitinib Citrate API Upstream (Raw Materials)
Table 161. Tofacitinib Citrate API Typical Customers
Table 162. Tofacitinib Citrate API Typical Distributors
List of Figure
Figure 1. Tofacitinib Citrate API Picture
Figure 2. World Tofacitinib Citrate API Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tofacitinib Citrate API Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 5. World Tofacitinib Citrate API Average Price (2018-2029) & (US$/Kg)
Figure 6. World Tofacitinib Citrate API Production Value Market Share by Region (2018-2029)
Figure 7. World Tofacitinib Citrate API Production Market Share by Region (2018-2029)
Figure 8. North America Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 9. Europe Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 10. China Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 11. Japan Tofacitinib Citrate API Production (2018-2029) & (Tons)
Figure 12. Tofacitinib Citrate API Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 15. World Tofacitinib Citrate API Consumption Market Share by Region (2018-2029)
Figure 16. United States Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 17. China Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 18. Europe Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 19. Japan Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 20. South Korea Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 22. India Tofacitinib Citrate API Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Tofacitinib Citrate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Tofacitinib Citrate API Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Tofacitinib Citrate API Markets in 2022
Figure 26. United States VS China: Tofacitinib Citrate API Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Tofacitinib Citrate API Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tofacitinib Citrate API Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 30. China Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Tofacitinib Citrate API Production Market Share 2022
Figure 32. World Tofacitinib Citrate API Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Tofacitinib Citrate API Production Value Market Share by Type in 2022
Figure 34. 0.98
Figure 35. 0.99
Figure 36. Others
Figure 37. World Tofacitinib Citrate API Production Market Share by Type (2018-2029)
Figure 38. World Tofacitinib Citrate API Production Value Market Share by Type (2018-2029)
Figure 39. World Tofacitinib Citrate API Average Price by Type (2018-2029) & (US$/Kg)
Figure 40. World Tofacitinib Citrate API Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Tofacitinib Citrate API Production Value Market Share by Application in 2022
Figure 42. Tablets
Figure 43. Others
Figure 44. World Tofacitinib Citrate API Production Market Share by Application (2018-2029)
Figure 45. World Tofacitinib Citrate API Production Value Market Share by Application (2018-2029)
Figure 46. World Tofacitinib Citrate API Average Price by Application (2018-2029) & (US$/Kg)
Figure 47. Tofacitinib Citrate API Industry Chain
Figure 48. Tofacitinib Citrate API Procurement Model
Figure 49. Tofacitinib Citrate API Sales Model
Figure 50. Tofacitinib Citrate API Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now